abt-652
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2010 (NCT01124851)
Timeline
Indications
Mechanism of action
- Histamine H3 receptorINHIBITOR
HRH3 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- abt-652
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01579279 | Phase 2 | Apr 1, 2012 | AbbVie |
| NCT01444365 | Phase 2 | Oct 1, 2011 | AbbVie |
| NCT01207115 | Phase 2 | Sep 1, 2010 | AbbVie |
| NCT01124851 | Phase 1 | Aug 1, 2010 | Abbott |
Showing 4 of 4 trials
Page 1 / 1